Skip to main content

Table 1 Patients’ characteristics

From: Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis

Characteristics of 46 patients

Results

Age [years], mean, standard deviation

71, 6.9

PSA value [ng/ml], median, range

3.76, 0.32–113.7

Disease duration [months], median, range

41, 0–192

Days between [68Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007, mean, standard deviation, median

12, 8.0, 13

Indication [n; %]

 Primary staging

10; 21.7%

 Biochemical recurrence

30; 65.2%

  After RPx

26 (86.7%)

  After RTx/Brachytherapy

4 (13.3%)

 Follow-up/PRLT-evaluation

6; 13.0%

Gleason score (GSC)

n

6

2 (4.3%)

7

20 (43.5%)

8

6 (13.0%)

9

18 (39.1%)

10

0

  1. RPx, radical prostatectomy; RTx, radiotherapy